Mechanisms underlying microbial-mediated changes in social behavior in mouse models of Autism Spectrum Disorder

By M. Sgritta, Sean W. Dooling, Shelly A Buffington, E. Momin, Michael B. Francis, R. Britton, Mauro Costa-Mattioli. Neuron, 2018

714 citations recorded by the source corpus.

SUMMARY Currently, there are no medications that effectively treat the core symptoms of Autism Spectrum Disorder (ASD). We recently found that the bacterial species Lactobacillus (L.) reuteri reverses social deficits in maternal high-fat diet offspring. However, whether the effect of L. reuteri on social behavior is generalizable to other ASD models and its mechanism(s) of action remain unknown. Here, we found that treatment with L. reuteri selectively rescues social deficits in genetic, environmental, and idiopathic ASD models. Interestingly, the effects of L. reuteri on social behavior are not mediated by restoring the composition of the host’s microbiome, which is altered in all of these ASD models. Instead, L. reuteri acts in a vagus nerve-dependent manner and rescues social interaction-induced synaptic plasticity in the ventral tegmental area of ASD mice, but not in oxytocin receptor-deficient mice. Collectively, treatment with L. reuteri emerges as promising non-invasive microbial-based avenue to combat ASD-related social dysfunction.

Subfields: Cognitive Neuroscience, Pharmacy, Social Psychology

View Paper: https://www.semanticscholar.org/paper/7c87563697ba7155d5b45141b0d43843a34325b2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

  1. Daniel H. Geschwind

In Pharmacy

  1. S. Mazmanian

In Social Psychology

  1. S. Mazmanian

Citations in the corpus